Erin Dunbar

2.4k total citations
46 papers, 663 citations indexed

About

Erin Dunbar is a scholar working on Genetics, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Erin Dunbar has authored 46 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 12 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Erin Dunbar's work include Glioma Diagnosis and Treatment (24 papers), Brain Metastases and Treatment (8 papers) and Immunotherapy and Immune Responses (5 papers). Erin Dunbar is often cited by papers focused on Glioma Diagnosis and Treatment (24 papers), Brain Metastases and Treatment (8 papers) and Immunotherapy and Immune Responses (5 papers). Erin Dunbar collaborates with scholars based in United States, United Kingdom and Canada. Erin Dunbar's co-authors include Anthony T. Yachnis, Bonnie S. Coats, Peter W. Stacpoole, Jonathan J. Shuster, Albert L. Shroads, Andrew M. Lew, Taimour Langaee, John R. Forder, David A. Wagner and Sajeve Thomas and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Erin Dunbar

42 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erin Dunbar United States 13 234 207 161 108 99 46 663
Okezie Obasi Kanu Nigeria 12 324 1.4× 314 1.5× 173 1.1× 100 0.9× 94 0.9× 42 968
Hiroshi Moritake Japan 17 301 1.3× 110 0.5× 78 0.5× 181 1.7× 119 1.2× 80 874
Jaclyn J. Renfrow United States 10 169 0.7× 234 1.1× 150 0.9× 68 0.6× 104 1.1× 24 619
Noam Asna Israel 10 196 0.8× 106 0.5× 93 0.6× 144 1.3× 103 1.0× 31 557
Adam L. Green United States 19 376 1.6× 283 1.4× 91 0.6× 137 1.3× 121 1.2× 55 923
Eric Lipp United States 19 246 1.1× 488 2.4× 152 0.9× 264 2.4× 186 1.9× 85 940
Patrick Thompson United States 15 299 1.3× 143 0.7× 82 0.5× 192 1.8× 96 1.0× 25 644
Shohei Yokota Japan 14 467 2.0× 408 2.0× 77 0.5× 242 2.2× 67 0.7× 57 1.5k
Carmen Fava Italy 18 198 0.8× 412 2.0× 73 0.5× 167 1.5× 122 1.2× 91 973
Jie Jin China 16 381 1.6× 94 0.5× 81 0.5× 341 3.2× 80 0.8× 64 913

Countries citing papers authored by Erin Dunbar

Since Specialization
Citations

This map shows the geographic impact of Erin Dunbar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Dunbar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Dunbar more than expected).

Fields of papers citing papers by Erin Dunbar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin Dunbar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Dunbar. The network helps show where Erin Dunbar may publish in the future.

Co-authorship network of co-authors of Erin Dunbar

This figure shows the co-authorship network connecting the top 25 collaborators of Erin Dunbar. A scholar is included among the top collaborators of Erin Dunbar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin Dunbar. Erin Dunbar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dunbar, Erin, et al.. (2024). Vorasidenib: Patient and caregiver information sheet. Neuro-Oncology Practice. 12(Supplement_1). i26–i28. 1 indexed citations
2.
Leung, Denise, Ashley Ghiaseddin, Jennie Taylor, et al.. (2024). Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients. Cancer. 130(9). 1577–1589. 1 indexed citations
3.
Mellon, Eric A., Mohammed Goryawala, Peter B. Barker, et al.. (2023). A Novel Approach to Determining Tumor Progression Using a Three-Site Pilot Clinical Trial of Spectroscopic MRI-Guided Radiation Dose Escalation in Glioblastoma. Tomography. 9(1). 362–374. 2 indexed citations
4.
Peereboom, David M., Ross Lindsay, Michael Badruddoja, et al.. (2023). CTIM-06. A PHASE 2 STUDY OF A NOVEL IMMUNOTHERAPY SL-701 IN ADULTS WITH RECURRENT GLIOBLASTOMA: EXPLORING THE PROGNOSTIC VALUE OF TREATMENT-INDUCED CD8+CD57+ T-CELLS AS A MARKER FOR SURVIVAL. Neuro-Oncology. 25(Supplement_5). v61–v62. 2 indexed citations
5.
Kim, Albert E., Kristin Waite, Manmeet S. Ahluwalia, et al.. (2021). Cross-sectional survey of patients, caregivers, and physicians on diagnosis and treatment of brain metastases. Neuro-Oncology Practice. 8(6). 662–673. 6 indexed citations
6.
Chukwueke, Ugonma, Elizabeth Vera, Alvina Acquaye, et al.. (2021). SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology. Neuro-Oncology. 23(11). 1845–1858. 5 indexed citations
7.
Arvold, Nils D., Terri S. Armstrong, Katherine E. Warren, et al.. (2018). Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group. Neuro-Oncology. 20(7). 897–906. 37 indexed citations
8.
Peereboom, David M., Burt Nabors, Priya Kumthekar, et al.. (2018). Phase 2 trial of SL-701 in relapsed/refractory (r/r) glioblastoma (GBM): Correlation of immune response with longer-term survival.. Journal of Clinical Oncology. 36(15_suppl). 2058–2058. 12 indexed citations
9.
Ballester, Leomar Y., Erin Dunbar, Nandita Guha‐Thakurta, et al.. (2018). Primary Leptomeningeal Oligodendroglioma, IDH-Mutant, 1p/19q-Codeleted. Frontiers in Neurology. 9. 700–700.
10.
Neill, Stewart G., David A. Solomon, Nicholas Butowski, et al.. (2017). Chordoid glioma of the third ventricle: report of a rapidly progressive case. Journal of Neuro-Oncology. 132(3). 487–495. 6 indexed citations
11.
Trusheim, John, Erin Dunbar, James Battiste, et al.. (2016). A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma. CNS Oncology. 6(1). 29–43. 35 indexed citations
12.
Dunbar, Erin, et al.. (2012). Unexpectedly Durable Palliation of Metastatic Olfactory Neuroblastoma Using Anti-Angiogenic Therapy with Bevacizumab. Rare Tumors. 4(2). 101–105. 12 indexed citations
13.
Dunbar, Erin & Anthony T. Yachnis. (2010). Glioma Diagnosis: Immunohistochemistry and Beyond. Advances in Anatomic Pathology. 17(3). 187–201. 47 indexed citations
14.
Dunbar, Erin. (2009). The Role of Chemotherapy for Pure and Mixed Anaplastic Oligodendroglial Tumors. Current Treatment Options in Oncology. 10(3-4). 216–230. 1 indexed citations
15.
Wallace, Adam N., Sameer R. Keole, Daniel J. Indelicato, et al.. (2008). Craniospinal Irradiation in the Management of Adult Medulloblastoma. International Journal of Radiation Oncology*Biology*Physics. 72(1). S202–S203.
16.
17.
18.
Grossman, Stuart A., Erin Dunbar, & Suzanne Nesbit. (2006). Cancer pain management in the 21st century.. PubMed. 20(11). 1333–9; discussion 1340. 4 indexed citations
19.
Wilkins, E.G.L., Matthew Ellis, Erin Dunbar, & Alan C. Gibbs. (1988). Does isolation of patients with infections induce mental illness?. Journal of Infection. 17(1). 43–47. 25 indexed citations
20.
Ellis, Michael, A.K. Webb, & Erin Dunbar. (1984). Toxoplasmosis associated with digital vasculitis and immunodeficiency—a dilemma in diagnosis. Postgraduate Medical Journal. 60(707). 616–617. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Okezie Obasi Kanu Breakdown of academic impact, for papers by Hiroshi Moritake Breakdown of academic impact, for papers by Jaclyn J. Renfrow Breakdown of academic impact, for papers by Noam Asna Breakdown of academic impact, for papers by Adam L. Green Breakdown of academic impact, for papers by Eric Lipp Breakdown of academic impact, for papers by Patrick Thompson Breakdown of academic impact, for papers by Shohei Yokota Breakdown of academic impact, for papers by Carmen Fava Breakdown of academic impact, for papers by Jie Jin
Rankless by CCL
2026